Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-02-15

Clinical Trial Update: Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA

View source ↗

Summary

This clinical trial update summarizes a mechanistic study in cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA) that investigates immu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pittsburgh | Conditions: Cystic Fibrosis, Allergic Bronchopulmonary Aspergillosis | Status: COMPLETED